American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$769M |
| 2 |
Kenvue
KVUE
|
+$204M |
| 3 |
Entegris
ENTG
|
+$176M |
| 4 |
Merck
MRK
|
+$148M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$143M |
Top Sells
| 1 |
Nike
NKE
|
+$278M |
| 2 |
Visa
V
|
+$272M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$228M |
| 4 |
Allstate
ALL
|
+$188M |
| 5 |
Wingstop
WING
|
+$165M |
Sector Composition
| 1 | Technology | 25.16% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Colony Bankcorp
CBAN
$304M
| $396K | ﹤0.01% |
34,395
+4,302
| +14% | +$49.5K |
|
|
INZY
2502
DELISTED
Inozyme Pharma
INZY
| $394K | ﹤0.01% |
51,427
+22,732
| +79% | +$174K |
|
2503
GoPro
GPRO
$327M
| $393K | ﹤0.01% |
176,380
+39,734
| +29% | +$88.6K |
|
2504
BrightView Holdings
BV
$1.32B
| $393K | ﹤0.01% |
+33,035
| New | +$393K |
|
2505
ESSA Pharma
EPIX
$9.6M
| $392K | ﹤0.01% |
46,176
+26,132
| +130% | +$222K |
|
|
GTY
2506
Getty Realty Corp
GTY
$1.6B
| $392K | ﹤0.01% |
14,322
+1,071
| +8% | +$29.3K |
|
2507
OmniAb
OABI
$236M
| $391K | ﹤0.01% |
72,073
+1,153
| +2% | +$6.25K |
|
2508
KalVista Pharmaceuticals
KALV
$708M
| $388K | ﹤0.01% |
32,723
+3,660
| +13% | +$43.4K |
|
|
VZIO
2509
DELISTED
VIZIO Holding Corp.
VZIO
| $387K | ﹤0.01% |
35,407
-3,354,574
| -99% | -$36.7M |
|
|
SHYF
2510
DELISTED
The Shyft Group
SHYF
| $386K | ﹤0.01% |
31,109
+7,218
| +30% | +$89.6K |
|
|
NTST
2511
NETSTREIT Corp
NTST
$1.75B
| $386K | ﹤0.01% |
20,995
+3,222
| +18% | +$59.2K |
|
|
FARO
2512
DELISTED
Faro Technologies
FARO
| $385K | ﹤0.01% |
17,910
+2,393
| +15% | +$51.5K |
|
|
LUCK
2513
Lucky Strike Entertainment Corporation
LUCK
$1.38B
| $385K | ﹤0.01% |
28,101
-265
| -0.9% | -$3.63K |
|
2514
Allient
ALNT
$779M
| $383K | ﹤0.01% |
+10,740
| New | +$383K |
|
2515
National CineMedia
NCMI
$455M
| $383K | ﹤0.01% |
74,378
+29,319
| +65% | +$151K |
|
2516
UNIFI
UFI
$82.8M
| $379K | ﹤0.01% |
63,282
+388
| +0.6% | +$2.32K |
|
2517
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $379K | ﹤0.01% |
9,046
+3,460
| +62% | +$145K |
|
2518
Axogen
AXGN
$755M
| $378K | ﹤0.01% |
46,815
+29,913
| +177% | +$241K |
|
2519
iRadimed
IRMD
$907M
| $376K | ﹤0.01% |
8,555
+2,849
| +50% | +$125K |
|
|
ELME
2520
Elme Communities
ELME
$1.51B
| $376K | ﹤0.01% |
26,985
+3,488
| +15% | +$48.6K |
|
2521
CoreCard
CCRD
$211M
| $374K | ﹤0.01% |
33,859
+2,229
| +7% | +$24.6K |
|
2522
Gannett
GCI
$620M
| $373K | ﹤0.01% |
153,016
+49,479
| +48% | +$121K |
|
2523
Brown-Forman Class A
BF.A
$13.2B
| $371K | ﹤0.01% |
7,010
-171
| -2% | -$9.05K |
|
2524
Silgan Holdings
SLGN
$4.71B
| $369K | ﹤0.01% |
7,590
+27
| +0.4% | +$1.31K |
|
|
TSVT
2525
DELISTED
2seventy bio
TSVT
| $367K | ﹤0.01% |
68,590
+23,246
| +51% | +$124K |
|